Sinsin Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio
Sinsin Pharmaceutical Co. Ltd cash flow-to-debt ratio. Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of ₩4.70 Billion could theoretically repay 0% of its total liabilities (₩65.10 Billion) in one year. Check Sinsin Pharmaceutical Co. Ltd (002800) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sinsin Pharmaceutical Co. Ltd (2016–2024)
Cash flow-to-debt ratio of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024. Historical debt coverage capacity for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Check total reinvestment intensity of Sinsin Pharmaceutical Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
Sinsin Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio by Year (2016–2024)
Sinsin Pharmaceutical Co. Ltd cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Sinsin Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see Sinsin Pharmaceutical Co. Ltd (002800) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | ₩5.94 Billion | ₩63.61 Billion | ▲ +48.2% |
| 2023 | 0.06x | ₩3.93 Billion | ₩62.32 Billion | ▼ -29.0% |
| 2022 | 0.09x | ₩5.46 Billion | ₩61.52 Billion | ▲ +22636.2% |
| 2021 | 0.00x | ₩23.18 Million | ₩59.38 Billion | ▼ -98.7% |
| 2020 | 0.03x | ₩1.87 Billion | ₩61.94 Billion | ▲ +148.7% |
| 2019 | -0.06x | ₩-4.51 Billion | ₩72.87 Billion | ▼ -526.3% |
| 2018 | 0.01x | ₩774.24 Million | ₩53.38 Billion | ▼ -91.5% |
| 2017 | 0.17x | ₩4.57 Billion | ₩26.74 Billion | ▲ +110.2% |
| 2016 | 0.08x | ₩2.79 Billion | ₩34.38 Billion | — |